148 related articles for article (PubMed ID: 25557260)
1. Clinicopathologic analysis of spindle cell/sclerosing rhabdomyosarcoma.
Yasui N; Yoshida A; Kawamoto H; Yonemori K; Hosono A; Kawai A
Pediatr Blood Cancer; 2015 Jun; 62(6):1011-6. PubMed ID: 25557260
[TBL] [Abstract][Full Text] [Related]
2. Do patients with metastatic and recurrent rhabdomyosarcoma benefit from high-dose therapy with hematopoietic rescue? Report of the German/Austrian Pediatric Bone Marrow Transplantation Group.
Koscielniak E; Klingebiel TH; Peters C; Hermann J; Burdach ST; Bender-Götze C; Müller-Weihrich ST; Treuner J
Bone Marrow Transplant; 1997 Feb; 19(3):227-31. PubMed ID: 9028550
[TBL] [Abstract][Full Text] [Related]
3. [Clinicopathologic features of pleomorphic rhabdomyosarcoma].
Yu L; Wang J
Zhonghua Bing Li Xue Za Zhi; 2013 Mar; 42(3):147-52. PubMed ID: 23769431
[TBL] [Abstract][Full Text] [Related]
4. Histopathological, immunohistochemical and molecular cytogenetic analysis of 21 spindle cell/sclerosing rhabdomyosarcomas.
Rekhi B; Singhvi T
APMIS; 2014 Nov; 122(11):1144-52. PubMed ID: 24730567
[TBL] [Abstract][Full Text] [Related]
5. Spindle cell rhabdomyosarcoma in adults.
Nascimento AF; Fletcher CD
Am J Surg Pathol; 2005 Aug; 29(8):1106-13. PubMed ID: 16006807
[TBL] [Abstract][Full Text] [Related]
6. Sarcoma of the prostate: a single institutional review.
Janet NL; May AW; Akins RS
Am J Clin Oncol; 2009 Feb; 32(1):27-9. PubMed ID: 19194120
[TBL] [Abstract][Full Text] [Related]
7. Establishment and characterization of NCC-ssRMS2-C1: a novel patient-derived cell line of spindle cell/sclerosing rhabdomyosarcoma.
Tsuchiya R; Yoshimatsu Y; Noguchi R; Sin Y; Ono T; Sei A; Takeshita F; Sugaya J; Nakatani F; Yoshida A; Ohtori S; Kawai A; Kondo T
Hum Cell; 2021 Sep; 34(5):1569-1578. PubMed ID: 34164773
[TBL] [Abstract][Full Text] [Related]
8. Epithelioid rhabdomyosarcoma: clinicopathologic analysis of 16 cases of a morphologically distinct variant of rhabdomyosarcoma.
Jo VY; Mariño-Enríquez A; Fletcher CD
Am J Surg Pathol; 2011 Oct; 35(10):1523-30. PubMed ID: 21921782
[TBL] [Abstract][Full Text] [Related]
9. MYOD1-mutant spindle cell and sclerosing rhabdomyosarcoma: an aggressive subtype irrespective of age. A reappraisal for molecular classification and risk stratification.
Agaram NP; LaQuaglia MP; Alaggio R; Zhang L; Fujisawa Y; Ladanyi M; Wexler LH; Antonescu CR
Mod Pathol; 2019 Jan; 32(1):27-36. PubMed ID: 30181563
[TBL] [Abstract][Full Text] [Related]
10. Adult rhabdomyosarcoma: outcome following multimodality treatment.
Little DJ; Ballo MT; Zagars GK; Pisters PW; Patel SR; El-Naggar AK; Garden AS; Benjamin RS
Cancer; 2002 Jul; 95(2):377-88. PubMed ID: 12124838
[TBL] [Abstract][Full Text] [Related]
11. Spindle cell/sclerosing rhabdomyosarcoma: case series from a single institution emphasizing morphology, immunohistochemistry and follow-up.
Zhao Z; Yin Y; Zhang J; Qi J; Zhang D; Ma Y; Wang Y; Li S; Zhou J
Int J Clin Exp Pathol; 2015; 8(11):13814-20. PubMed ID: 26823695
[TBL] [Abstract][Full Text] [Related]
12. The expanding morphological and genetic spectrum of MYOD1-mutant spindle cell/sclerosing rhabdomyosarcomas: a clinicopathological and molecular comparison of mutated and non-mutated cases.
Tsai JW; ChangChien YC; Lee JC; Kao YC; Li WS; Liang CW; Liao IC; Chang YM; Wang JC; Tsao CF; Yu SC; Huang HY
Histopathology; 2019 May; 74(6):933-943. PubMed ID: 30604891
[TBL] [Abstract][Full Text] [Related]
13. Myogenin and desmin immunohistochemistry in the assessment of post-chemotherapy genitourinary embryonal rhabdomyosarcoma: prognostic and management implications.
Godbole P; Outram A; Wilcox DT; Duffy PG; Sebire NJ
J Urol; 2006 Oct; 176(4 Pt 2):1751-4. PubMed ID: 16945640
[TBL] [Abstract][Full Text] [Related]
14. Sclerosing rhabdomyosarcomas in children and adolescents: a clinicopathologic review of 13 cases from the Intergroup Rhabdomyosarcoma Study Group and Children's Oncology Group.
Chiles MC; Parham DM; Qualman SJ; Teot LA; Bridge JA; Ullrich F; Barr FG; Meyer WH;
Pediatr Dev Pathol; 2004; 7(6):583-94. PubMed ID: 15630526
[TBL] [Abstract][Full Text] [Related]
15. Anaplastic sarcoma of the kidney: a clinicopathologic study of 20 cases of a new entity with polyphenotypic features.
Vujanić GM; Kelsey A; Perlman EJ; Sandstedt B; Beckwith JB
Am J Surg Pathol; 2007 Oct; 31(10):1459-68. PubMed ID: 17895746
[TBL] [Abstract][Full Text] [Related]
16. [Rhabdomyosarcoma in middle to old-aged patients: analysis of clinicopathological features and prognosis in 76 cases].
Yu L; Wang J
Zhonghua Zhong Liu Za Zhi; 2012 Dec; 34(12):910-6. PubMed ID: 23336377
[TBL] [Abstract][Full Text] [Related]
17. Rhabdomyosarcoma in children--a ten year review.
Bradford WB; Jose BO; Butler D; Lindberg RD; Paris K; Spanos WJ; Patel CC; Bertolone SJ
J Ky Med Assoc; 1998 Oct; 96(10):399-402. PubMed ID: 9803061
[TBL] [Abstract][Full Text] [Related]
18. Analysis of prognostic factors in patients with nonmetastatic rhabdomyosarcoma treated on intergroup rhabdomyosarcoma studies III and IV: the Children's Oncology Group.
Meza JL; Anderson J; Pappo AS; Meyer WH;
J Clin Oncol; 2006 Aug; 24(24):3844-51. PubMed ID: 16921036
[TBL] [Abstract][Full Text] [Related]
19. Initial patient characteristics can predict pattern and risk of relapse in localized rhabdomyosarcoma.
Dantonello TM; Int-Veen C; Winkler P; Leuschner I; Schuck A; Schmidt BF; Lochbuehler H; Kirsch S; Hallmen E; Veit-Friedrich I; Bielack SS; Niggli F; Kazanowska B; Ladenstein R; Wiebe T; Klingebiel T; Treuner J; Koscielniak E
J Clin Oncol; 2008 Jan; 26(3):406-13. PubMed ID: 18202417
[TBL] [Abstract][Full Text] [Related]
20. Stage 1 embryonal rhabdomyosarcoma of the female genital tract: a retrospective clinical study of nine cases.
Yuan G; Yao H; Li X; Li H; Wu L
World J Surg Oncol; 2017 Feb; 15(1):42. PubMed ID: 28173865
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
